Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.
Issue link: http://outpatientsurgery.uberflip.com/i/1051280
Like a scene out of a video game, a virtual version of the optimal surgical pathway is superimposed over the endo- scopic image surgeons view when operating. The virtual track appears brightly on the screen when surgeons move instruments through its center, says Dr. Senior, but the track darkens if the instruments begin to stray to one side or the other. Surgeons watch their progress along the virtual pathway and make adjustments on the fly as necessary to remain on the right (and safe) track. That real-time feedback provides surgeons with added reassurance as they manipulate instruments around the frontal sinus cavity, which is millimeters away from the brain and orbital cavities, says Dr. Senior. Clinical guidelines call for the use of the image-guided technol- ogy during revision sinus surgery or when operating on patients with complex sinus anatomy, but Dr. Senior says a growing num- Janice TIF 2.0 Procedure A Safe, Durable Clinical Solution to Manage Troublesome GERD SymptomT With a strong record of clinical success, proven in multiple randomized clinical trials, you can be certain the TIF® procedure will help your patients get back to living. 81% of TIF patients no longer use PPIs daily 1 84% Esophagitis healed or improved one grade 2 81% Significantly improved quality of life scores 3 www.EndoGastricSolutions.com 1 Across 11 studies in 568 patients reporting >6 months PPI use. Across 3 studies in 120 patients at >5 years 78% report no daily PPI use. 2 Across 2 studies in 56 patients reporting >36 months on follow-up endoscopy 3 Across 10 studies in 545 patients reporting >6 months follow-up on GERD-HRQL (p<0.001) The TIF® procedure is designed to treat GERD symptoms with the EsophyX® technology – a cleared device. Results may vary; visit GERDHelp.com for clinical data. EndoGastric Solutions, Inc. is the manufacturer and owner of these trademarks: TIF, EsophyX and SerosaFuse. ©2018 All rights reserved. NP02456-01G GERD has taken a lot from your patients. Help Janice re-claim herself. Janice TIF 2.0 Procedure A Safe, Durable Clinical Solution to Manage Troublesome GERD SymptomT With a strong record of clinical success, proven in multiple randomized clinical trials, you can be certain the TIF® procedure will help your patients get back to living. 81% of TIF patients no longer use PPIs daily 1 84% Esophagitis healed or improved one grade 2 81% Significantly improved quality of life scores 3 www.EndoGastricSolutions.com 1 Across 11 studies in 568 patients reporting >6 months PPI use. Across 3 studies in 120 patients at >5 years 78% report no daily PPI use. 2 Across 2 studies in 56 patients reporting >36 months on follow-up endoscopy 3 Across 10 studies in 545 patients reporting >6 months follow-up on GERD-HRQL (p<0.001) The TIF® procedure is designed to treat GERD symptoms with the EsophyX® technology – a cleared device. Results may vary; visit GERDHelp.com for clinical data. EndoGastric Solutions, Inc. is the manufacturer and owner of these trademarks: TIF, EsophyX and SerosaFuse. ©2018 All rights reserved. NP02456-01G GERD has taken a lot from your patients. Help Janice re-claim herself.